These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

580 related articles for article (PubMed ID: 27974677)

  • 1. Histone demethylase lysine demethylase 5B in development and cancer.
    Han M; Xu W; Cheng P; Jin H; Wang X
    Oncotarget; 2017 Jan; 8(5):8980-8991. PubMed ID: 27974677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KDM5B is a master regulator of the H3K4-methylome in stem cells, development and cancer.
    Xhabija B; Kidder BL
    Semin Cancer Biol; 2019 Aug; 57():79-85. PubMed ID: 30448242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The histone-H3K4-specific demethylase KDM5B binds to its substrate and product through distinct PHD fingers.
    Klein BJ; Piao L; Xi Y; Rincon-Arano H; Rothbart SB; Peng D; Wen H; Larson C; Zhang X; Zheng X; Cortazar MA; Peña PV; Mangan A; Bentley DL; Strahl BD; Groudine M; Li W; Shi X; Kutateladze TG
    Cell Rep; 2014 Jan; 6(2):325-35. PubMed ID: 24412361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448.
    Bamodu OA; Huang WC; Lee WH; Wu A; Wang LS; Hsiao M; Yeh CT; Chao TY
    BMC Cancer; 2016 Feb; 16():160. PubMed ID: 26917489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies of H3K4me3 demethylation by KDM5B/Jarid1B/PLU1 reveals strong substrate recognition in vitro and identifies 2,4-pyridine-dicarboxylic acid as an in vitro and in cell inhibitor.
    Kristensen LH; Nielsen AL; Helgstrand C; Lees M; Cloos P; Kastrup JS; Helin K; Olsen L; Gajhede M
    FEBS J; 2012 Jun; 279(11):1905-14. PubMed ID: 22420752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the histone demethylase, KDM5B, directly induces re-expression of tumor suppressor protein HEXIM1 in cancer cells.
    Montano MM; Yeh IJ; Chen Y; Hernandez C; Kiselar JG; de la Fuente M; Lawes AM; Nieman MT; Kiser PD; Jacobberger J; Exner AA; Lawes MC
    Breast Cancer Res; 2019 Dec; 21(1):138. PubMed ID: 31805991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The PHD1 finger of KDM5B recognizes unmodified H3K4 during the demethylation of histone H3K4me2/3 by KDM5B.
    Zhang Y; Yang H; Guo X; Rong N; Song Y; Xu Y; Lan W; Zhang X; Liu M; Xu Y; Cao C
    Protein Cell; 2014 Nov; 5(11):837-50. PubMed ID: 24952722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coordinated regulation of retinoic acid signaling pathway by KDM5B and polycomb repressive complex 2.
    Zhang Y; Liang J; Li Q
    J Cell Biochem; 2014 Sep; 115(9):1528-38. PubMed ID: 24619877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KDM5B demethylates H3K4 to recruit XRCC1 and promote chemoresistance.
    Xu W; Zhou B; Zhao X; Zhu L; Xu J; Jiang Z; Chen D; Wei Q; Han M; Feng L; Wang S; Wang X; Zhou J; Jin H
    Int J Biol Sci; 2018; 14(9):1122-1132. PubMed ID: 29989047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysine demethylase 5B (KDM5B): A potential anti-cancer drug target.
    Zheng YC; Chang J; Wang LC; Ren HM; Pang JR; Liu HM
    Eur J Med Chem; 2019 Jan; 161():131-140. PubMed ID: 30343192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SUMOylation negatively modulates target gene occupancy of the KDM5B, a histone lysine demethylase.
    Bueno MT; Richard S
    Epigenetics; 2013 Nov; 8(11):1162-75. PubMed ID: 23970103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone demethylase KDM5B is a key regulator of genome stability.
    Li X; Liu L; Yang S; Song N; Zhou X; Gao J; Yu N; Shan L; Wang Q; Liang J; Xuan C; Wang Y; Shang Y; Shi L
    Proc Natl Acad Sci U S A; 2014 May; 111(19):7096-101. PubMed ID: 24778210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depletion of histone demethylase KDM5B inhibits cell proliferation of hepatocellular carcinoma by regulation of cell cycle checkpoint proteins p15 and p27.
    Wang D; Han S; Peng R; Jiao C; Wang X; Yang X; Yang R; Li X
    J Exp Clin Cancer Res; 2016 Feb; 35():37. PubMed ID: 26911146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation of the histone demethylase KDM5B and regulation of the phenotype of triple negative breast cancer.
    Yeh IJ; Esakov E; Lathia JD; Miyagi M; Reizes O; Montano MM
    Sci Rep; 2019 Nov; 9(1):17663. PubMed ID: 31776402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PLU-1 is an H3K4 demethylase involved in transcriptional repression and breast cancer cell proliferation.
    Yamane K; Tateishi K; Klose RJ; Fang J; Fabrizio LA; Erdjument-Bromage H; Taylor-Papadimitriou J; Tempst P; Zhang Y
    Mol Cell; 2007 Mar; 25(6):801-12. PubMed ID: 17363312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a Linked Jumonji Domain of the KDM5/JARID1 Family of Histone H3 Lysine 4 Demethylases.
    Horton JR; Engstrom A; Zoeller EL; Liu X; Shanks JR; Zhang X; Johns MA; Vertino PM; Fu H; Cheng X
    J Biol Chem; 2016 Feb; 291(6):2631-46. PubMed ID: 26645689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting histone demethylase KDM5B for cancer treatment.
    Fu YD; Huang MJ; Guo JW; You YZ; Liu HM; Huang LH; Yu B
    Eur J Med Chem; 2020 Dec; 208():112760. PubMed ID: 32883639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KDM5B focuses H3K4 methylation near promoters and enhancers during embryonic stem cell self-renewal and differentiation.
    Kidder BL; Hu G; Zhao K
    Genome Biol; 2014 Feb; 15(2):R32. PubMed ID: 24495580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysine demethylase 5B suppresses CC chemokine ligand 14 to promote progression of colorectal cancer through the Wnt/β-catenin pathway.
    Yan G; Li S; Yue M; Li C; Kang Z
    Life Sci; 2021 Jan; 264():118726. PubMed ID: 33160990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone lysine demethylase KDM5B maintains chronic myeloid leukemia via multiple epigenetic actions.
    Xue S; Lam YM; He Z; Zheng Y; Li L; Zhang Y; Li C; Mbadhi MN; Zheng L; Cheng Z; Liu Y; Wang X; Chan LC; Ng RK; Zhang J
    Exp Hematol; 2020 Feb; 82():53-65. PubMed ID: 32007477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.